Advanced theranostic materials / / edited by Ashutosh Tiwari, Hirak K. Patra and Jeong-Woo Choi |
Pubbl/distr/stampa | Salem, Massachusetts : , : Scrivener Publishing |
Descrizione fisica | 1 online resource (360 p.) |
Disciplina | 616.07/54 |
Collana | Advanced material series |
Soggetto topico |
Diagnostic imaging
Nanotechnology - Health aspects Nanomedicine Cancer - Treatment |
ISBN |
1-118-99891-X
1-118-99892-8 1-118-99889-8 |
Classificazione | TEC021000 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover; Title Page; Copyright; Contents; Preface; Part 1: System Biology and Translational Medicine; 1 Aberrant Signaling Pathways; 1.1 Cancer; 1.2 Pathways Deregulated in Cancer: Introduction; 1.3 Introduction to Nanotechnology; 1.3.1 Overview of Clinical Nanotechnology; 1.3.2 Current Usage in Cancer Treatment; 1.4 Current Uses in Cancer Diagnostic; 1.4.1 The Phosphatidylinositol 3-Kinase-AKT Pathway; 1.4.2 The MAPK Pathway; 1.4.3 mTOR Pathway; 1.4.4 Receptor Tyrosine Kinase; Acknowledgment; References; 2 Application of Nanoparticles in Cancer Treatment; 2.1 Introduction; 2.1.1 Nanotechnology
2.1.2 Nanobiotechnology2.1.3 Nanotechnology in Medicine; 2.1.4 Cancer and Nano in Medicine; 2.2 Nanoparticles in Cancer Treatment; 2.3 Nanoparticle Platforms as Drug Delivery Systems for Cancer Therapy; 2.3.1 Lipid-based Nanoparticle Platforms; 2.3.2 Polymer-based Nanoparticle Platforms; 2.3.3 Protein-based Nanoparticle Platforms; 2.3.4 Inorganic Nanoparticle Platforms; 2.4 Theranostic Nanomedicine; 2.4.1 Theranostic Nanomedicine for Cancer Therapy; 2.5 Selective Drug Delivery and Encapsulation for Chemotherapy; 2.6 Stimuli-Sensitive Nanopreparations; 2.7 Multifunctional Nanopreparations 2.8 Cancer Nanotechnology: Future and ChallengesReferences; 3 Biomacromolecule-Gated Mesoporous Silica Drug Delivery Systems for Stimuli-Responsive Controlled Release; 3.1 Introduction; 3.2 Protein-Gated MSN Drug Delivery Systems; 3.2.1 Ligand-Binding Protein-Gated MSN Systems; 3.2.2 Metal-Chelating Protein-Gated MSN Systems; 3.3 DNA-Gated MSN Drug Delivery Systems; 3.3.1 Single-Stranded DNA-Gated MSN Systems; 3.3.2 Double-Stranded DNA-Gated MSN Systems; 3.3.3 Hairpin or Quadruplex DNA-Gated MSN Systems; 3.3.4 Native DNA-Gated MSN Systems 3.3.5 Near-Infrared Light-Triggered DNA-Gated MSN Systems3.4 Conclusions and Perspectives; Acknowledgments; References; 4 Construction of Functional DNA Nanostructures for Theranostic Applications; 4.1 The Progress of Structural DNA Nanotechnology; 4.2 DNA Nanostructures for Diagnostics; 4.3 DNA Nanostructures for Diagnostics on the Interface; 4.4 Diagnostic in Homogeneous Solution; 4.4.1 Spherical Nucleic Acids (SNA) Probes for Detections in Solution; 4.4.2 Nanochips in Solution; 4.4.3 Intracellular/In Vivo Diagnosis; 4.5 DNA Nanostructures for Therapeutics 4.5.1 Delivery of Small-Molecular Drugs4.5.2 Delivery of CpG DNAs; 4.5.3 RNA Interference (RNAi); 4.5.4 Delivery of Proteins; 4.6 Integration of Diagnosis and Therapy: Smart DNA Theranostic Nanodevices; 4.7 Targeted Delivery; 4.8 Controlled/Triggered Release; 4.9 Summary and Perspectives; 4.9.1 The Bioeffects of DNA Nanostructures; 4.9.2 Purity and Yield; 4.9.3 Dynamic Structures for Theranostic; References; Part 2: Imaging and Therapeutics; 5 Dimercaptosuccinic Acid-Coated Magnetic Nanoparticles as a Localized Delivery System in Cancer Immunotherapy; 5.1 Introduction 5.1.1 Nanoparticle-based Drug Delivery Systems |
Record Nr. | UNINA-9910131511603321 |
Salem, Massachusetts : , : Scrivener Publishing | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Advanced theranostic materials / / edited by Ashutosh Tiwari, Hirak K. Patra and Jeong-Woo Choi |
Pubbl/distr/stampa | Salem, Massachusetts : , : Scrivener Publishing |
Descrizione fisica | 1 online resource (360 p.) |
Disciplina | 616.07/54 |
Collana | Advanced material series |
Soggetto topico |
Diagnostic imaging
Nanotechnology - Health aspects Nanomedicine Cancer - Treatment |
ISBN |
1-118-99891-X
1-118-99892-8 1-118-99889-8 |
Classificazione | TEC021000 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover; Title Page; Copyright; Contents; Preface; Part 1: System Biology and Translational Medicine; 1 Aberrant Signaling Pathways; 1.1 Cancer; 1.2 Pathways Deregulated in Cancer: Introduction; 1.3 Introduction to Nanotechnology; 1.3.1 Overview of Clinical Nanotechnology; 1.3.2 Current Usage in Cancer Treatment; 1.4 Current Uses in Cancer Diagnostic; 1.4.1 The Phosphatidylinositol 3-Kinase-AKT Pathway; 1.4.2 The MAPK Pathway; 1.4.3 mTOR Pathway; 1.4.4 Receptor Tyrosine Kinase; Acknowledgment; References; 2 Application of Nanoparticles in Cancer Treatment; 2.1 Introduction; 2.1.1 Nanotechnology
2.1.2 Nanobiotechnology2.1.3 Nanotechnology in Medicine; 2.1.4 Cancer and Nano in Medicine; 2.2 Nanoparticles in Cancer Treatment; 2.3 Nanoparticle Platforms as Drug Delivery Systems for Cancer Therapy; 2.3.1 Lipid-based Nanoparticle Platforms; 2.3.2 Polymer-based Nanoparticle Platforms; 2.3.3 Protein-based Nanoparticle Platforms; 2.3.4 Inorganic Nanoparticle Platforms; 2.4 Theranostic Nanomedicine; 2.4.1 Theranostic Nanomedicine for Cancer Therapy; 2.5 Selective Drug Delivery and Encapsulation for Chemotherapy; 2.6 Stimuli-Sensitive Nanopreparations; 2.7 Multifunctional Nanopreparations 2.8 Cancer Nanotechnology: Future and ChallengesReferences; 3 Biomacromolecule-Gated Mesoporous Silica Drug Delivery Systems for Stimuli-Responsive Controlled Release; 3.1 Introduction; 3.2 Protein-Gated MSN Drug Delivery Systems; 3.2.1 Ligand-Binding Protein-Gated MSN Systems; 3.2.2 Metal-Chelating Protein-Gated MSN Systems; 3.3 DNA-Gated MSN Drug Delivery Systems; 3.3.1 Single-Stranded DNA-Gated MSN Systems; 3.3.2 Double-Stranded DNA-Gated MSN Systems; 3.3.3 Hairpin or Quadruplex DNA-Gated MSN Systems; 3.3.4 Native DNA-Gated MSN Systems 3.3.5 Near-Infrared Light-Triggered DNA-Gated MSN Systems3.4 Conclusions and Perspectives; Acknowledgments; References; 4 Construction of Functional DNA Nanostructures for Theranostic Applications; 4.1 The Progress of Structural DNA Nanotechnology; 4.2 DNA Nanostructures for Diagnostics; 4.3 DNA Nanostructures for Diagnostics on the Interface; 4.4 Diagnostic in Homogeneous Solution; 4.4.1 Spherical Nucleic Acids (SNA) Probes for Detections in Solution; 4.4.2 Nanochips in Solution; 4.4.3 Intracellular/In Vivo Diagnosis; 4.5 DNA Nanostructures for Therapeutics 4.5.1 Delivery of Small-Molecular Drugs4.5.2 Delivery of CpG DNAs; 4.5.3 RNA Interference (RNAi); 4.5.4 Delivery of Proteins; 4.6 Integration of Diagnosis and Therapy: Smart DNA Theranostic Nanodevices; 4.7 Targeted Delivery; 4.8 Controlled/Triggered Release; 4.9 Summary and Perspectives; 4.9.1 The Bioeffects of DNA Nanostructures; 4.9.2 Purity and Yield; 4.9.3 Dynamic Structures for Theranostic; References; Part 2: Imaging and Therapeutics; 5 Dimercaptosuccinic Acid-Coated Magnetic Nanoparticles as a Localized Delivery System in Cancer Immunotherapy; 5.1 Introduction 5.1.1 Nanoparticle-based Drug Delivery Systems |
Record Nr. | UNINA-9910820125903321 |
Salem, Massachusetts : , : Scrivener Publishing | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|